AMRN
Amarin Corp Plc\Uk
$14.88
-0.24 (-1.59%)
At close · Jul 10
Market Cap
$6.55B
Shares
439,915,526
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$213.65M
-6.5%
FY2025
Net Income
-$38.8M
+52.8%
FY2025
Gross Margin
56.57%
+21pp
FY2025
Operating Margin
-23.48%
+16.7pp
FY2025
Diluted EPS
-$0.09
+55%
FY2025
Operating Cash Flow
$6.73M
+121.7%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $216.76M | $213.65M | $228.61M | $306.91M | $369.19M | $583.19M | $614.06M | $429.76M | $229.21M | $181.1M | $130.08M | $81.76M | $54.2M | $26.35M | — | — | — | — | |
| $1.05M | $1.05M | $1.06M | $912K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| $115.24M | — | — | — | — | $121.33M | $131.44M | $96.02M | $54.54M | $44.95M | $34.36M | $27.88M | $20.49M | $11.91M | — | — | — | — | |
| $113.51M | $120.87M | $81.38M | $165.54M | $242.48M | $461.86M | $482.62M | $333.74M | $174.67M | $136.15M | $95.72M | $53.88M | $33.72M | $14.44M | — | — | — | — | |
| — | 56.57% | 35.6% | 53.94% | 65.68% | 79.2% | 78.59% | 77.66% | 76.2% | 75.18% | 73.58% | 65.9% | 62.21% | 54.79% | — | — | — | — | |
| $19.16M | $19.81M | $20.87M | $22.22M | $30.41M | $29.31M | $38.96M | $34.39M | $55.9M | $47.16M | $49.98M | $51.06M | $50.33M | $72.75M | $58.96M | $21.6M | $28.01M | $20.89M | |
| $46.38M | $43.75M | $38.29M | $52.56M | $75.26M | — | — | — | — | — | — | — | — | — | $57.79M | $22.56M | $17.09M | $13.15M | |
| $99.55M | $115M | $152.31M | $199.94M | $304.42M | $408.33M | $463.31M | $323.62M | $227M | $134.55M | $111.37M | $101.04M | $79.35M | $123.8M | $57.79M | $22.56M | — | — | |
| — | $3.02M | $2.92M | $2.81M | $2.55M | $2.27M | $1.44M | $679K | $646K | $646K | $645K | $646K | $646K | $646K | $269K | — | — | — | |
| — | — | — | — | — | — | — | — | $23K | $62K | $138K | $166K | $198K | $246K | $180K | $76K | $63K | $583K | |
| — | $36.23M | $0 | $10.97M | $13.53M | $13.72M | — | — | — | — | — | — | — | — | — | — | — | — | |
| $158.26M | $171.04M | $173.18M | $233.13M | $348.35M | $451.36M | $502.27M | $358.02M | $282.9M | $181.71M | $161.35M | $152.1M | $129.67M | $196.55M | $116.75M | $44.16M | $45.1M | $34.04M | |
| -$44.75M | -$50.17M | -$91.8M | -$67.59M | -$105.87M | $10.5M | -$19.66M | -$24.28M | -$108.23M | -$45.56M | -$65.63M | -$98.22M | -$95.96M | -$182.11M | -$116.75M | -$44.16M | -$45.1M | -$34.04M | |
| — | -23.48% | -40.15% | -22.02% | -28.68% | 1.8% | -3.2% | -5.65% | -47.22% | -25.15% | -50.45% | -120.14% | -177.03% | -691.08% | — | — | — | — | |
| — | — | — | — | — | — | — | — | -$108.2M | -$45.49M | -$65.49M | -$98.06M | -$95.76M | -$181.86M | -$116.57M | -$44.09M | -$45.04M | -$33.46M | |
| — | $7000 | $7000 | $8000 | $15K | $129K | $2.61M | $6.63M | $8.87M | $9.77M | $18.68M | $20.18M | $18.58M | $34.18M | $18.09M | $1000 | $19K | $2.83M | |
| — | $10.85M | $13.4M | $11.86M | $2.82M | $1.22M | $4.9M | $8.5M | $1.07M | $429K | $234K | $132K | $96K | $343K | $544K | $231K | $53K | $199K | |
| $3.21M | $3.28M | $1.2M | $2.06M | -$740K | -$302K | $104K | -$75K | -$326K | $74K | -$482K | -$228K | $3.73M | -$1.19M | -$427K | -$10K | $130K | $33K | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $700K | |
| -$31.14M | -$36.05M | -$77.2M | -$53.67M | -$103.81M | $11.29M | -$17.26M | -$22.48M | -$116.35M | -$54.82M | -$76.38M | -$118.29M | -$59.2M | -$169.42M | -$170.07M | -$66.61M | -$250.09M | -$31.51M | |
| $2.47M | $2.75M | $4.98M | $5.44M | $2M | $3.56M | $745K | $164K | $96K | $13.05M | $9.97M | -$3.09M | -$2.84M | -$3.19M | $9.12M | $2.52M | -$501K | -$901K | |
| -$33.61M | -$38.8M | -$82.18M | -$59.11M | -$105.8M | $7.73M | -$18M | -$22.65M | -$116.45M | -$67.87M | -$86.35M | -$115.2M | -$56.36M | -$166.23M | -$179.18M | -$69.13M | -$249.59M | -$30.61M | |
| — | -18.16% | -35.95% | -19.26% | -28.66% | 1.33% | -2.93% | -5.27% | -50.8% | -37.47% | -66.38% | -140.91% | -103.99% | -630.82% | — | — | — | — | |
| -$33.61M | -$38.8M | -$82.18M | -$59.11M | -$105.8M | $7.73M | — | — | — | -$67.87M | -$86.35M | -$149.06M | -$56.36M | -$166.23M | -$179.18M | -$69.13M | — | — | |
| USD/shares | — | -$0.09 | -$0.20 | -$0.15 | -$5.20 | $0.40 | -$1.00 | -$1.40 | -$7.80 | -$5.00 | -$8.20 | -$16.60 | -$6.40 | -$20.60 | -$24.80 | -$10.60 | — | — |
| USD/shares | — | -$0.09 | -$0.20 | -$0.15 | -$5.20 | $0.40 | -$1.00 | -$1.40 | -$7.80 | -$5.00 | -$8.20 | -$16.60 | -$7.20 | -$25.60 | -$24.80 | -$10.60 | — | — |
| shares | — | 414.98M | 410.94M | 407.66M | 20.06M | 19.8M | 19.09M | 17.13M | 14.86M | 13.53M | 10.59M | 9.03M | 8.69M | 8.05M | 7.2M | 6512.35 | — | — |
| shares | — | 414.98M | 410.94M | 407.66M | 20.06M | 20.12M | 19.09M | 17.13M | 14.86M | 13.53M | 10.59M | 9.03M | 8.69M | 8.35M | 7.2M | 6512.35 | — | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Drug Manufacturers - General median 3.18×
EV/EBIT
—
P/E (TTM)
—
Drug Manufacturers - General median 23.35×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Product & Service (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|
| Product | $182,753,000 | $204,590,000 | $285,299,000 | $366,511,000 | $580,320,000 | $607,025,000 | $427,391,000 | $228,371,000 |
| Licensing and Royalty | $30,893,000 | $24,024,000 | $21,612,000 | $2,682,000 | $2,867,000 | $7,035,000 | $2,364,000 | $843,000 |